Alignment Healthcare Executive Compensation (FY25)
ALHC · Executive and director compensation, fiscal 2022 to 2025
The Alignment Healthcare brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Data as of September 19, 2026Latest filing (8-K): June 9, 2026
8 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
$1,500Get the executive brief
246 figures on this page: 242 cited to the filing that reported them, 4 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — John Kao: $6,369,165 → $11,278,583 (77.1% higher)
Say-on-pay support: 98.6% → 94.8% (3.8 points lower)
CEO pay ratio: 90:1 → 158:1 (75.6% higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is Alignment Healthcare's chief executive and what were they paid?
John Kao was paid $11,278,583 in total compensation as Chief Executive Officer for fiscal 2025. Kao's total moved 77.1% higher from the $6,369,165 reported for fiscal 2024.
What was Alignment Healthcare's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 94.8% of votes cast including abstentions in favor at the meeting held June 4, 2026.
Which companies are in Alignment Healthcare's peer group?
Companies named in the disclosed peer group include AdaptHealth Corp., agilon health, inc., Astrana Health, Inc., Bausch & Lomb Corp. and Clover Health Investments Corp., among others.
What is Alignment Healthcare's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 158:1, against median employee compensation of $71,260.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
John Kao Director and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Dawn Maroney President, Markets | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Dinesh Kumar Chief Medical and Operating Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Thomas Freeman Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Richard Cross General Counsel and Corporate Secretary | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
John Kao Chief Executive Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Dawn Maroney President | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Thomas Freeman Chief Financial Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Hyong Kim Chief Medical Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Andreas Wagner Chief Human Resources Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
John Kao Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Dawn Maroney President | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
James Head Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Hyong Kim Chief Medical Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Christopher Joyce Chief Legal & Administrative Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Thomas Freeman Former Chief Financial Officer Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | — not reconciled |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Christopher Joyce | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Christopher Joyce | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Dawn Maroney | PSU | ◇ | — | ◇ | — | ◇ | — | ◇ |
| Dawn Maroney | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Hyong Kim | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Hyong Kim | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| James M. Head | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| James M. Head | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| John Kao | PSU | ◇ | — | ◇ | — | ◇ | — | ◇ |
| John Kao | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Thomas Freeman | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Thomas Freeman | PSU | ◇ | — | ◇ | — | ◇ | — | ◇ |
| Thomas Freeman | RSU | ◇ | — | — | ◇ | — | — | ◇ |
Fiscal 2022, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Dawn Maroney | Option | ◇ | — | ◇ | 3/8/2032 |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| John Kao | Option | ◇ | — | ◇ | 3/8/2032 |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Thomas Freeman | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Christopher Joyce | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Hyong Kim | PSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| James Head | PSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Christopher Joyce
Chief Legal & Administrative Officer · Employment agreement · dated August 1, 2023
| Severance multiple | ◇ |
| Benefits continuation | ◇ |
| Non-solicit period | ◇ |
| Clawback | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Joseph Konowiecki Board chair | ◇ | ◇ | — | — | — | — | ◇ |
Margaret McCarthy Lead independent director | ◇ | ◇ | — | — | — | — | ◇ |
Jacqueline Kosecoff | ◇ | ◇ | — | — | — | — | ◇ |
Yon Jorden | ◇ | ◇ | — | — | — | — | ◇ |
David Hodgson | ◇ | ◇ | — | — | — | — | ◇ |
Jody Bilney | ◇ | ◇ | — | — | — | — | ◇ |
Robbert Vorhoff | ◇ | ◇ | — | — | — | — | ◇ |
Mark McClellan | ◇ | ◇ | — | — | — | — | ◇ |
John Kao served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Lead independent director premium | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Equity is delivered as restricted stock units.
Stock ownership guideline: Officer and director stock ownership requirements
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- AdaptHealth Corp. AHCO
- agilon health, inc. AGL
- Astrana Health, Inc. ASTH
- Bausch & Lomb Corp. BLCO
- Clover Health Investments Corp. CLOV
- DaVita Inc. DVA
- Ensign Group, Inc. ENSG
- Evolent Health, Inc. EVH
- Option Care Health, Inc. OPCH
- Oscar Health, Inc. OSCR
- Pediatrix Medical Group, Inc. MD
- Privia Health Group, Inc. PRVA
- Quest Diagnostics Inc. DGX
- RadNet, Inc. RDNT
- Select Medical Holdings Corp. SEM
- Teladoc Health, Inc. TDOC
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | June 4, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | June 5, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | June 7, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | June 6, 2023 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
What this page does not include
Everything above is a fact Alignment Healthcare disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Alignment Healthcare sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
246 figures on this page: 242 cited to the filing that reported them, 4 calculated from figures it prints.
242 cited to the filing
4 calculated from the filing
Documents cited
- 0001628280-26-041926
- 0001628280-26-027058CEO Pay Ratio · EACH OF THE ABOVE DIRECTOR NOMINEES. · EXECUTIVE AND DIRECTOR COMPENSATION · Grants of Plan-Based Awards · and 1 more section
- 0001628280-26-012545EX-10.10
- 0001628280-25-030795Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001628280-25-019952Summary Compensation Table
- 0001628280-24-027889
- 0000950170-23-027311Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000950170-23-014906Summary Compensation Table
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Alignment Healthcare executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/ALHC (accessed 2026).
Short form: data: Velarion
The Alignment Healthcare brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
8 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Alignment Healthcare and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Peers Alignment Healthcare discloses
The companies named in ALHC's own disclosed peer group.
AdaptHealth Corp.agilon health, inc.Astrana Health, Inc.Bausch & Lomb Corp.Clover Health Investments Corp.DaVita Inc.Ensign Group, Inc.Evolent Health, Inc.Option Care Health, Inc.Oscar Health, Inc.Pediatrix Medical Group, Inc.Privia Health Group, Inc.Quest Diagnostics Inc.RadNet, Inc.Select Medical Holdings Corp.Teladoc Health, Inc.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}